Education Library

Resources for Health Care Professionals

Filter Results





December 7, 2021

Clinical Analysis of Impella® in High-Risk PCI

Alexandra Lansky, MD, discusses a propensity-adjusted population-based analysis of Impella in patients undergoing high-risk PCI from a large-scale claims dataset. 

November 5, 2021

TCT 2021: SCAI Shock Stage Update

Srihari Naidu, MD discusses updates to the SCAI shock stages at TCT 2021.

November 4, 2021

TCT 2021: MCS During High-Risk PCI and PROTECT IV

Gregg Stone, MD, reviews evidence for the use of mechanical circulatory support during high-risk PCI and provides an overview of the PROTECT IV RCT.

November 3, 2021

Best Practices for Treating High-Risk PCI Patients

Jason Wollmuth, MD, discusses large-bore access and intravascular imaging best practices for treating high-risk PCI patients.

November 3, 2021

Improved Outcomes with Contemporary Practices in PROTECT III

Jeffrey Moses, MD, discusses the improved outcomes with contemporary practices seen in the PROTECT III study of Impella-supported high-risk PCI.

November 3, 2021

HFSA 2021: Identifying Patients for PROTECT IV

Navin Kapur, MD, explains the importance of identifying patients with heart failure who can be enrolled in the PROTECT IV trial.

November 3, 2021

Protected PCI as a Practical Approach to MCS in Elective Complex Cases

William O’Neill, MD, discusses Protected PCI as a practical approach to mechanical circulatory support in elective complex PCI cases.

November 3, 2021

HFSA 2021: Management Considerations for HFCS

Jaime Hernandez-Montfort, MD, discusses management considerations for heart failure cardiogenic shock (HFCS) at HFSA 2021.

November 2, 2021

HFSA 2021: Clinical Evidence to Support ‘On-Pump’ Complex PCI in Heart Failure

Navin Kapur, MD, discusses clinical evidence to support ‘on-pump’ complex PCI for patients with heart failure.

November 1, 2021

HFSA 2021: Cardiogenic Shock Patients Can Achieve Heart Recovery

Shelley Hall, MD, discusses what can be done about cardiogenic shock and where the field is going, and issues a call for achieving heart recovery.

October 29, 2021

Data-Driven Point-of-Care Risk Model in Patients with AMICS

Ole Helgestad, PhD, discusses an automated variable selection method for predicting 30-day mortality in patients with AMICS receiving acute PCI. 

October 28, 2021

HFSA 2021: Identifying Patients Who Would Benefit from Complete Revascularization

Cindy Grines, MD, presents data and clinical insights regarding complete revascularization and which patients might benefit from it.

October 27, 2021

HFSA 2021: Defining and Achieving Heart Recovery

Manreet Kanwar, MD, discusses the topic of heart recovery: How do we define it? How do we achieve it?

October 26, 2021

HFSA 2021: MCS in High-Risk PCI Evidence from PROTECT II through PROTECT IV

Gregg Stone, MD, reviews available data—from PROTECT II through PROTECT IV—for use of mechanical circulatory support during high-risk PCI.

October 25, 2021

HFSA 2021: Time for a Paradigm Shift in High-Risk Cardiac Surgery

Daniel Goldstein, MD, discusses high-risk cardiac surgery from the STICH trial to a preview of the IMPACT trial that has received FDA IDE approval.